EGFR and triple-negative breast carcinoma: Qing et al. showed that SPRY1 has a selective function in a subset of EGFR expressed Triple-Negative Breast Cancer (TNBC) by promoting the aggressive phenotype via enhancing the EGF-mediated mesenchymal phenotype (He et al., 2016).